Apervita, formerly known as Pervasive Health, raised an $18 million Series A round led by GE Ventures and Baird Capital, and with participation from Pritzker Group Venture Capital, Math Ventures and existing investors.

The money will be used for further development of Apervita’s platform, and to expand sales and marketing team to promote the platform and address growing market demands.

The company offers health analytics marketplace with growing repository of analytics, includes evidenced-based content from top academic medical centers.“By combining marketplace economics, cloud computing and light-touch streaming implementation, Apervita will fundamentally change the way healthcare is delivered,” said Noah Lewis, managing director of healthcare at GE Ventures. “Their innovative business model aligns perfectly with our vision for data-driven, predictive healthcare, and we look forward to helping them scale through this next stage of expansion.”

The company offers health analytics marketplace with growing repository of analytics, includes evidenced-based content from top academic medical centers, such as Mayo Clinic. This information addresses many fundamental provider challenges in areas that include chronic disease management, preventable adverse events, readmissions, cancer, early warning, quality and safety. The portfolio will soon expand with operational and financial areas, as well.

For instance, one algorithm developed at Mayo Clinic allows physicians to utilize the Apervita platform to analyze information stored in medical records, identifying high risk patients in most need of an implantable cardiac defibrillator.

Apervita’s HIPAA-compliant cloud platform was developed with seed funding secured in 2013. Since then, it has proven effective at scale with providers in the U.S. and U.K., across tens of millions of patient facts and hundreds of users.